544
Views
2
CrossRef citations to date
0
Altmetric
State of the Art Review

Chronic Renal Disorder after a Nuclear Crisis: A Brief Review

Pages 749-750 | Received 29 Apr 2011, Accepted 01 May 2011, Published online: 25 Jul 2011

REFERENCES

  • Romanenko A, Morell-Quadreny L, Nepomnyaschy V, Vozianov A, Llombart-Bosch A. Pathology and proliferative activity of renal-cell carcinomas (RCCS) and renal oncocytomas in patients with different radiation exposure after the Chernobyl accident in Ukraine. Int J Cancer. 2000;87(6):880–883.
  • Blanco Espinosa A, Leva Vallejo M, Merlo de la Peña F, Moreno Arcas P, Carazo Carazo JL, Requena Tapia MJ. Association of renal carcinoma and the exposure to ionizing radiation after the Chernobyl accident. Actas Urol Esp. 2003;27(2):164–167.
  • Romanenko A, Morell-Quadreny L, Nepomnyaschy V, Vozianov A, Llombart-Bosch A. Radiation sclerosing proliferative atypical nephropathy of peritumoral tissue of renal-cell carcinomas after the Chernobyl accident in Ukraine. Virchows Arch. 2001;438(2):146–153.
  • Romanenko A, Morell-Quadreny L, Lopez-Guerrero JA, p16INK4A and p15INK4B gene alteration associated with oxidative stress in renal cell carcinomas after the chernobyl accident (pilot study). Diagn Mol Pathol. 2002;11(3):163–169.
  • Romanenko A, Morell-Quadreny L, Lopez-Guerrero JA, The INK4a/ARF locus: Role in cell cycle control for renal cell epithelial tumor growth after the Chernobyl accident. Virchows Arch. 2004;445(3):298–304.
  • Romanenko A, Morell-Quadreny L, Ramos D, Nepomnyaschiy V, Vozianov A, Llombart-Bosch A. Extracellular matrix alterations in conventional renal cell carcinomas by tissue microarray profiling influenced by the persistent, long-term, low-dose ionizing radiation exposure in humans. Virchows Arch. 2006;448(5):584–590.
  • Semidotskaia ZhD, Bil’chenko OS, Popovskaia TN, Cherniakova IA, Nikiforova NA, Misiura OI. The characteristics of the immunity status of people with arterial hypertension who took part in the cleanup of the aftermath of the accident at the Chernobyl Atomic Electric Power Station. Lik Sprava. 1996;3–4:27–30.
  • Konchalovsky MV, Baranov AE, Kolganov AV. Multiple organ involvement and failure: Selected Russian radiation accident cases re-visited. BJR Suppl. 2005;27:26–29.
  • Verzijl JM, Wierckx FC, van Dijk A, Savelkoul TJ, Glerum JH. Hemodialysis as a potential method for the decontamination of persons exposed to radiocesium. Health Phys. 1995;69(4):543–548.
  • Dam K, Bankl H, Mostbeck A. Measurements of radiocesium incorporation in 250 deceased patients who died within a year following Chernobyl. Wien Klin Wochenschr. 1988;100(7):193–197.
  • Vozianov OF, Pyrih LA, Nikulina HH, Pasiechnikov SP, Dudar IO. The metabolic aspects of the sequelae of the accident at the Chernobyl Atomic Electric Power Station in the course of kidney diseases. Lik Sprava. 1995;5–6:15–19.
  • Petrova A, Gnedko T, Maistrova I, Zafranskaya M, Dainiak N. Morbidity in a large cohort study of children born to mothers exposed to radiation from Chernobyl. Stem Cells. 1997;15(Suppl. 2):141–150.
  • Kulakov VI, Sokur TN, Volobuev AI, Female reproductive function in areas affected by radiation after the Chernobyl power station accident. Environ Health Perspect. 1993;101(Suppl. 2):117–123.
  • Tissandie E, Guéguen Y, Lobaccaro JM, Vitamin D metabolism impairment in the rat’s offspring following maternal exposure to 137cesium. Arch Toxicol. 2009;83(4):357–362.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.